Financial statements Solpharma Plus
Balance sheet of Solpharma Plus
Company age:
Age:
14 y. 9 m. 11 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of SOLPHARMA PLUS
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 595 953,23 | 455 029,26 | 215 678,70 | 242 203,71 | 336 238,21 | 585 416,83 |
| A. Fixed assets | 27 100,00 | 27 100,00 | 27 100,00 | 27 100,00 | 41 000,00 | 46 000,00 |
| B. Current assets | 568 853,23 | 427 929,26 | 188 578,70 | 215 103,71 | 295 238,21 | 539 416,83 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | - | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | - | - |
| Total liabilities | 595 953,23 | 455 029,26 | 215 678,70 | 242 203,71 | 336 238,21 | 585 416,83 |
| A. Equity | 277 677,77 | 326 813,95 | -36 687,11 | -10 872,17 | -152 405,43 | -67 879,69 |
| B. Liabilities and provisions for liabilities | 318 275,46 | 128 215,31 | 252 365,81 | 253 075,88 | 488 643,64 | 653 296,52 |
| I. Long-term liabilities | 0,00 | 0,00 | 179 432,88 | 0,00 | - | - |
| II. Short-term liabilities | 318 275,46 | 128 215,31 | 72 932,93 | 253 075,88 | 454 723,64 | 590 636,52 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.